These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 15051765

  • 1. Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer.
    Heemskerk MH, Hoogeboom M, Hagedoorn R, Kester MG, Willemze R, Falkenburg JH.
    J Exp Med; 2004 Apr 05; 199(7):885-94. PubMed ID: 15051765
    [Abstract] [Full Text] [Related]

  • 2. Kinetic preservation of dual specificity of coprogrammed minor histocompatibility antigen-reactive virus-specific T cells.
    van Loenen MM, Hagedoorn RS, Kester MG, Hoogeboom M, Willemze R, Falkenburg JH, Heemskerk MH.
    Cancer Res; 2009 Mar 01; 69(5):2034-41. PubMed ID: 19223543
    [Abstract] [Full Text] [Related]

  • 3. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.
    Spaapen R, van den Oudenalder K, Ivanov R, Bloem A, Lokhorst H, Mutis T.
    Clin Cancer Res; 2007 Jul 01; 13(13):4009-15. PubMed ID: 17606735
    [Abstract] [Full Text] [Related]

  • 4. Adult and cord blood T cells can acquire HA-1 specificity through HA-1 T-cell receptor gene transfer.
    Mommaas B, van Halteren AG, Pool J, van der Veken L, Wieles B, Heemskerk MH, Goulmy E.
    Haematologica; 2005 Oct 01; 90(10):1415-21. PubMed ID: 16219579
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gene transfer for activation of CMV specific T cells.
    André-Schmutz I, Dal Cortivo L, Hamel Y, Cavazzana-Calvo M.
    Hum Immunol; 2004 May 01; 65(5):565-70. PubMed ID: 15172458
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of host immunity to cytomegalovirus pp150 (UL32).
    La Rosa C, Wang Z, Lacey SF, Markel SF, Sharma MC, Martinez J, Lalimarmo MM, Diamond DJ.
    Hum Immunol; 2005 Feb 01; 66(2):116-26. PubMed ID: 15694996
    [Abstract] [Full Text] [Related]

  • 13. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P, Bold G, Presber F, Biti D, Babel N, Kreutzer S, Pratschke J, Schönemann C, Kern F, Volk HD, Reinke P.
    Transpl Immunol; 2009 Mar 01; 20(4):238-42. PubMed ID: 19032982
    [Abstract] [Full Text] [Related]

  • 14. HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.
    van Balen P, Jedema I, van Loenen MM, de Boer R, van Egmond HM, Hagedoorn RS, Hoogstaten C, Veld SAJ, Hageman L, van Liempt PAG, Zwaginga JJ, Meij P, Veelken H, Falkenburg JHF, Heemskerk MHM.
    Front Immunol; 2020 Mar 01; 11():1804. PubMed ID: 32973756
    [Abstract] [Full Text] [Related]

  • 15. Conservation of minor histocompatibility antigens between human and non-human primates.
    den Haan JM, Bontrop RE, Pool J, Sherman N, Blokland E, Engelhard VH, Hunt DF, Goulmy E.
    Eur J Immunol; 1996 Nov 01; 26(11):2680-5. PubMed ID: 8921955
    [Abstract] [Full Text] [Related]

  • 16. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
    Melenhorst JJ, Solomon SR, Shenoy A, Hensel NF, McCoy JP, Keyvanfar K, Barrett AJ.
    J Immunother; 2006 Nov 01; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
    [Abstract] [Full Text] [Related]

  • 17. Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.
    Gras S, Saulquin X, Reiser JB, Debeaupuis E, Echasserieau K, Kissenpfennig A, Legoux F, Chouquet A, Le Gorrec M, Machillot P, Neveu B, Thielens N, Malissen B, Bonneville M, Housset D.
    J Immunol; 2009 Jul 01; 183(1):430-7. PubMed ID: 19542454
    [Abstract] [Full Text] [Related]

  • 18. Genetic engineering of virus-specific T cells with T-cell receptors recognizing minor histocompatibility antigens for clinical application.
    Griffioen M, van Egmond HM, Barnby-Porritt H, van der Hoorn MA, Hagedoorn RS, Kester MG, Schwabe N, Willemze R, Falkenburg JH, Heemskerk MH.
    Haematologica; 2008 Oct 01; 93(10):1535-43. PubMed ID: 18768532
    [Abstract] [Full Text] [Related]

  • 19. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
    Willemsen R, Ronteltap C, Heuveling M, Debets R, Bolhuis R.
    Gene Ther; 2005 Jan 01; 12(2):140-6. PubMed ID: 15496961
    [Abstract] [Full Text] [Related]

  • 20. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
    Karlsson H, Brewin J, Kinnon C, Veys P, Amrolia PJ.
    J Immunother; 2007 Jan 01; 30(5):544-56. PubMed ID: 17589295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.